about
Improved predictive ability of the Montreal Cognitive Assessment for diagnosing dementia in a community-based study.Risk of subsequent attention-deficit/hyperactivity disorder among children and adolescents with amalgam restorations: A nationwide longitudinal study.Antiviral therapy reduces risk of haemorrhagic stroke in patients with HCV infection: a nationwide cohort study.Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.Increased Risk of New-Onset Hypertension After Shock Wave Lithotripsy in Urolithiasis: A Nationwide Cohort Study.Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.Association between Emotional Symptoms and Job Demands in an Asian Electronics Factory.Age modifies the risk factor profiles for acute kidney injury among recently diagnosed type 2 diabetic patients: a population-based study.Identifying Unmet Treatment Needs for Patients With Osteoporotic Fracture: Feasibility Study for an Electronic Clinical Surveillance System.Both pre-frailty and frailty increase healthcare utilization and adverse health outcomes in patients with type 2 diabetes mellitusAcarbose Use and Liver Injury in Diabetic Patients With Severe Renal Insufficiency and Hepatic Diseases: A Propensity Score-Matched Cohort StudyCan government-supported preventive fluoride varnish application service reduce pulp-involved primary molars?Risk for Suicidal Behavior Among Psoriasis Patients: A Nationwide Cohort StudyA Web-Based Clinical System for Cohort Surveillance of Specific Clinical Effectiveness and Safety Outcomes: A Cohort Study of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin
P50
Q36263205-8B8BE53F-4036-47D8-9218-208694EE6703Q38646187-F56FF4B1-A850-4E33-8D0A-232A018622EFQ38805059-6DCFEFF5-6F06-4C8F-9CD0-099DE5FE0CDEQ38922538-9750EA17-5AEC-4A04-95BE-2BD8BF050D1CQ39594065-DA8A90E2-1633-4A9C-8824-ECFBEAB3861FQ40076077-A47772D5-A408-40D1-ADE0-D987A306D2D8Q40380906-761380D2-5333-4400-97B7-97054FDD04C4Q41659401-441655E5-64FE-4C88-9DD4-9CF442223DEFQ55072100-CF859FD4-B433-43E5-BD13-6F70B211DA98Q55312663-2BD0F471-BB81-460F-BF16-F497A31EFD8CQ58691957-26C0D815-876C-44BD-AD66-B1283BD2E864Q58797244-AE803B25-4000-4770-AE78-FC160CDFC2A8Q90261409-59DD06E8-034F-4C2A-AB0D-6331942B7D7CQ91538901-74C0135F-958A-4CC7-84A4-49498A78BBD7Q91601311-10BF52F0-5788-4BF5-92BF-A570B0DDE073
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jui Wang
@en
Jui Wang
@nl
type
label
Jui Wang
@en
Jui Wang
@nl
prefLabel
Jui Wang
@en
Jui Wang
@nl
P31
P496
0000-0003-4800-5276